A New Startup Promises to Preserve Your Brain Intact

If your end-of-life goals include preserving your brain completely intact at the synaptic level so it can potentially be reproduced in microdetail in the distant future and your consciousness reborn, then you’re in luck! A company called Nectome, with financial support from the U.S. National Institute of Mental Health and the startup accelerator Y Combinator, plans to provide you this opportunity.

Nectome has perfectly preserved a pig brain—and amazingly, the brain of a recently deceased woman—using their technique. However, because the process requires the brain’s owner to be alive, the woman’s brain sustained some damage. Their success with the pig brain creates hope for a special population—terminally ill humans who wish to be euthanized using this technique.

Unfortunately, the procedure is literally a suicide mission, which of course raises ethical and legal concerns. Euthanasia is a crime in many states. However, with the end goal being life reproduced, the federal financing targets the development of the process, revitalizing brain research.

Those who undergo the future revival procedure should not expect their consciousness to emerge in the future as themselves. The brain dies in this process, experiencing a combination of cryogenics and embalming. If successful, an identical consciousness with all your precious memories, knowledge, and wisdom would be would be created. That’s a lot to wrap your head around.

Scientists hypothesize that consciousness is a product of the architecture of the neural network instead of some other aspect of the brain, such as its biochemical composition or nucleic acid sequences. Right now, we do not know enough to guarantee specific outcomes. This research would undoubtedly answer many questions. However, as with countless other biomedical experiments, there may be no definitive answers to ethical questions surrounding the wisdom and intentions of manipulating life in this manner. Regardless of these issues, the technique will likely yield promising, much-needed neurological research. And we will be one step closer to solving the mysteries of the human brain.

Follow us on social media for the latest updates in B2B!


BioTech Startups Want to Revive Failed Medicines to Create New Lifesaving Treatments
Behind the Clinical Trials for Non-Alcohol Fatty Liver Disease that Can Benefit 30% of Americans
July 1, 2022
  The Impact Research Institute (IRI) is Waco, Texas’ resource for extending care options for NAFLD (non-alcohol fatty liver disease.) Nadege Gunn is IRI’s Medical Director and President. She Read more
FABTECH Show Kickoff and Overview of Solutions Distributed by DeGeest
June 30, 2022
This is another episode of Manufacturing A Stronger Standard live from FABTECH 2021. Host and President of LestaUSA and DeGeest Corp., Derek DeGeest, talked with Brad Ruppert, Engineering Manager, and Read more
Improving Quality and Bottomline for Finishing Operations
June 30, 2022
This is another episode of Manufacturing A Stronger Standard from FABTECH 2021. Host and President of Lesta USA and Degeest Corp., Derek Degeest, talked with Bill Robinson, President and Kris Bonnegent, Regional Read more